Episode Details

Testing and diagnostics services stocks wrapped up a solid fourth quarter, with RadNet leading the pack with a 14.8% revenue jump. Quest Diagnostics and Guardant Health also performed well, while NeoGenomics and Labcorp lagged. Despite positive results, investor reactions have been cool, with shares down an average of 13.1%. The sector faces demand from aging populations and chronic diseases, but pricing pressures and regulations loom large. AI diagnostics and personalized tests present opportunities for companies adapting quickly.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/99709e7a165abc35